Oral non-biologic therapies and non-pharmacological therapies in PsA

0Citations
Citations of this article
4Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Traditional disease-modifying antirheumatic drugs (DMARD) are the fi rst line for the treatment of psoriatic arthritis (PsA) globally, in spite of the lack of evidence from randomized control trials. Most of the evidence comes from observational studies that will be reviewed in this chapter. Rehabilitation in rheumatology focuses on prevention of functional disorders of the musculoskeletal system, maintenance of working ability and prevention of care dependency. Rehabilitation and physical therapy is part of non-pharmacological treatment in patients with rheumatic disease. Few studies have been identifi ed in PsA, related to this issue, and are included in this review. Finally, surgery is preferably preventable, but necessary in some cases. Evidence suggests that results of orthopedic surgery in PsA are similar to those reported in other infl ammatory diseases.

Cite

CITATION STYLE

APA

Soriano, E. R., & Felquer, M. L. A. (2016). Oral non-biologic therapies and non-pharmacological therapies in PsA. In Psoriatic Arthritis and Psoriasis: Pathology and Clinical Aspects (pp. 267–279). Springer International Publishing. https://doi.org/10.1007/978-3-319-19530-8_27

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free